reports
- ABGSC Capital Goods Research
- Anders Idborg
- Karl Bokvist
VOLV B VOLVO AB CLASS B
WRT1V WARTSILA OYJ ABP
ABB ABB LTD.
SAND SANDVIK AB
TREL B TRELLEBORG AB CLASS B
MOCORP METSO OUTOTEC OYJ
ASSA B ASSA ABLOY AB CLASS B
SKF B SKF AB CLASS B
HPOL B HEXPOL AB CLASS B
ALFA ALFA LAVAL AB
MTRS B MUNTERS GROUP
8TRA TRATON SE
HEXA B HEXAGON AB
EPI A EPIROC AB
NIBE B NIBE INDUSTRIER AB
ATCO A ATLAS COPCO AB
ALIV SDB AUTOLIV INC.
Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI ...
Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort February 12, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the availability of the InkSpace Imaging Snuggle™ pediatric body array coil for Philips 3.0T MRI systems. Designed specifically for pediatric patients, the Snuggle coil has been optimized and validated for use with Philips 3.0T MRI systems, bringing enhanced comfort for children and efficient, high-quality i...
- Ahmed Ben Salem
FP TOTAL SE
HEIA HEINEKEN NV
BVI BUREAU VERITAS SA
TKA TELEKOM AUSTRIA AG
GFC GECINA SA
ABB ABB LTD.
MF WENDEL SE
KER KERING SA
RAND RANDSTAD NV
SCHP SCHINDLER HOLDING AG PREF
RACE FERRARI NV
AD KONINKLIJKE AHOLD DELHAIZE N.V.
BP. BP P.L.C.
BG BAWAG GROUP AG
ENR SIEMENS ENERGY AG
DSY DASSAULT SYSTEMES SA
SGSN SGS SA
UN0 UNIPER SE
AENA AENA S.M.E. SA
TKMS TKMS AG & CO. KGAA
- Ahmed Ben Salem
HEIA HEINEKEN NV
BVI BUREAU VERITAS SA
TKA TELEKOM AUSTRIA AG
GFC GECINA SA
ABB ABB LTD.
MF WENDEL SE
KER KERING SA
RAND RANDSTAD NV
SCHP SCHINDLER HOLDING AG PREF
RACE FERRARI NV
AD KONINKLIJKE AHOLD DELHAIZE N.V.
BP. BP P.L.C.
BG BAWAG GROUP AG
ENR SIEMENS ENERGY AG
DSY DASSAULT SYSTEMES SA
SGSN SGS SA
UN0 UNIPER SE
AENA AENA S.M.E. SA
TKMS TKMS AG & CO. KGAA
- Jerôme Bodin
CEC CECONOMY AG
BVI BUREAU VERITAS SA
MF WENDEL SE
SZG SALZGITTER AG
DEC JCDECAUX SA
TYRES NOKIAN RENKAAT OYJ
ASY ASSYSTEM SA
GXI GERRESHEIMER AG
PIG HAULOTTE GROUP SA
VOE VOESTALPINE AG
CIE CIE AUTOMOTIVE S.A.
BRNL BRUNEL INTERNATIONAL N.V.
ROVI LABORATORIOS FARMACEUTICOS ROVI S.A.
COFA COFACE SA
ECONT ECONOCOM GROUP SE CLASS D
ALFEN ALFEN NV
TUI TUI AG
NCH2 THYSSENKRUPP NUCERA AG & CO.
SCHOTT PHARMA AG
AQ AQUILA PART PROD COM
AMS AMS-OSRAM AG
- Jerôme Bodin
CEC CECONOMY AG
BVI BUREAU VERITAS SA
MF WENDEL SE
SZG SALZGITTER AG
DEC JCDECAUX SA
TYRES NOKIAN RENKAAT OYJ
ASY ASSYSTEM SA
GXI GERRESHEIMER AG
PIG HAULOTTE GROUP SA
VOE VOESTALPINE AG
CIE CIE AUTOMOTIVE S.A.
BRNL BRUNEL INTERNATIONAL N.V.
ROVI LABORATORIOS FARMACEUTICOS ROVI S.A.
COFA COFACE SA
ECONT ECONOCOM GROUP SE CLASS D
ALFEN ALFEN NV
TUI TUI AG
NCH2 THYSSENKRUPP NUCERA AG & CO.
SCHOTT PHARMA AG
AQ AQUILA PART PROD COM
AMS AMS-OSRAM AG
- ING Helpdesk
Benelux Morning Notes
ABN Amro: Miss but strong capital, good set of results / Ahold Delhaize: Strong 4Q25 but no major surprise on FY26 adj. EPS guidance / Alfen: No recovery yet and another transitional year / BAM Group: Preview: 2026 outlook the key item / Econocom: Better REBITA, net debt, but EBIT below, much lower net profit, dividend halved, 2026-28 guidance postponed to “medium term” / Exor: Ferrari 4Q25 and 2026 guidance beat / Gecina: Results and guidance in line, DPS set to grow over 2026-30 / Heineken: No...
- Eya Drira
- Geoffroy Michalet
ODDO : Love lasts 3(0) years
Wendel has held shares in Bureau Veritas since 1995, but we expect the group to make a full exit in 2026 (15% of the capital of BVI remaining). With this move, Wendel would wrap up the divestment policy rolled out over the past two years, as it looks to deleverage its balance sheet and ensure strategic consistency with its equity story. Such an outcome would wipe out the structural overhang weighing on BV, leading to stock re-rating (Outperform rating and € 35 target price maintained). However, ...
- Eya Drira
- Geoffroy Michalet
ODDO : L’amour dure 3(0) ans
Alors que Wendel est actionnaire de Bureau Veritas depuis 1995 : nous tablons sur son désengagement total en 2026 (15% du capital de BVI restant), dans la continuité des deux dernières années, par besoin (de désendettement) et par cohérence (avec l’equity-story). Cette issue probable retirera l’overhang structurel qui affecte Bureau Veritas et conduira à un rerating (Surperformance et OC 35€ maintenus). En revanche, si elle permet la réduction de l’endettement de Wendel, les moteurs de croissanc...
- Oliver Metzger
- Wim Gille
- Oscar Rodriguez
PHILIPS: RDOS. 4T’25 Y CAMBIO DE P.O. AL ALZA (ANÁLISIS BANCO SABADELL...
Rdos. 4T’25 vs 4T’24: Ventas: 5.097 M euros (+1,1% vs -0,9% BS(e) y -1,0% consenso); EBITA Aj.: 770 M euros (+13,4% vs +0,6% BS(e) y -1,0% consenso); BDI: 397 M euros (-333 M euros en 2024 vs 275 M euros BS(e) y 276 M euros consenso); Rdos. 2025 vs 2024: Ventas: 17.834 M euros (-1,0% vs -1,6% BS(e) y -1,6% consenso); EBITA Aj.: 2.195 M euros (+5,7% vs +1,5% BS(e) y +1,0% consenso); BDI: 897 M euros (-698 M euros en 2024 vs 775 M euros BS(e) y 776 M euros consenso).
- Oliver Metzger
- Wim Gille
- ING Helpdesk
Benelux Morning Notes
Aedifica: c.€29m new developments in Germany and Finland / GBL: €0.5bn equity investment in Rayner, an ophthalmic MedTech specialist / NN Group: Is consensus running ahead of a capital update with FY25 results? / Philips: Supportive update ahead of CMD / Proximus: Route Mobile 3Q26 shows lower revenues, better profitability / Staffing sector: French staffing: December better but January outlook weaker but perhaps better than number of temp outlook indicates / VAR Energi: Strong CMD target 400kpd...
- Guy Sips
- Michiel Declercq
- Oliver Metzger
- Wim Gille
- Michiel Declercq
Philips Strong 4Q25 results and outlook, targets mid-teens margins by ...
Philips reported a strong set of 4Q25 results with the adj. EBITA of € 770m coming in well ahead of expectations (kbcse: € 678m, css: € 672m), predominantly driven by PH. Order intake remained strong at +7%. The FY26 margin outlook of 12.5%-13.0% also came in ahead of expectations (kbcse: 12.3%, css: 12.2%). Together with the CMD that will take place in London today, the group also announced its new 2026-2028 ambitions, including a mid-teens margins by 2028 (kbcse: 13.5%, css 13.6%) and accumula...
- Research Department
INFORME DIARIO 10 FEBRERO + RDOS. ESPAÑA Y EUROPA 4T’25. IDEAS DESTACA...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: AEDAS, INDRA. EUROPA: KERING, PHILIPS. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’25 que se publicarán en España y Europa en los próximos días. Recuperación en el mercado Subidas en las bolsas europeas, beneficiadas por el rebote global y la mejoría en la temporada de Rdos. Con un 27% de las compañía...
Philips delivers full year 2025 with growth acceleration, strong margi...
Philips delivers full year 2025 with growth acceleration, strong margin expansion and solid cash flow; announces 2026-2028 targets at Capital Markets Day Amsterdam, February 10, 2026Full year and Q4 highlights Comparable order intake growth 6% in 2025; up 7% in Q4Group sales of EUR 17.8 billion in 2025, EUR 5.1 billion in Q4; comparable sales growth 2% in 2025, 7% in Q4Income from operations was EUR 1,424 million in 2025; EUR 540 million in Q4Adjusted EBITA margin increased 80 basis points to 12.3% of sales in 2025; up 160 basis points to 15.1% in Q4Operating cash flow of EUR 1,172 million...
Philips proposes to re-appoint CEO Roy Jakobs
Philips proposes to re-appoint CEO Roy Jakobs February 10, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Roy Jakobs is proposed to be re-appointed as its President/Chief Executive Officer and member of the Board of Management. The decision to propose the re-appointment of Roy Jakobs reflects the Supervisory Board’s recognition of the progress made since 2022 and its confidence in his leadership as Philips enters the next phase of driving profitable growth. The proposal will be submitted for approval at the upcoming An...
BUREAU VERITAS: Number of shares and voting rights as of January 31, 2...
BUREAU VERITAS: Number of shares and voting rights as of January 31, 2026 REGULATED INFORMATION Courbevoie, France – February 6, 2026 Information on number of shares and voting rights as stipulated by article 223-16 of the general regulations of the French financial markets authority AMF Issuer: Bureau Veritas DateNumber of shares (1)Number of voting rights31/01/2026453,877,520Theoretical number of voting rights: 560,823,211Number of exercisable voting rights: 550,602,381 (1) including the new shares issued in Euroclear as a result of the exercise of stock options since January 1, 2026,...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.